Louise Zornoza from raps.org produced a very informational article on the impact of the reclassification deadline for hip, shoulder, and knee implants. Australia’s Therapeutics Goods Administration (TGA) has warned implant companies that they have only a few more months to complete the reclassification for their products. Implants are being reclassified by the TGA from a medium risk to a high risk July 1st. The TGA has tried to help companies by giving them a 2 year grace period to complete the reclassification of their products. To read the full article click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.